PortalPublikationenFDG PET/CT in cancer therapy monitoring. Computer-assisted a...

FDG PET/CT in cancer therapy monitoring. Computer-assisted analysis of baseline together with up to two follow-ups.

Standard

FDG PET/CT in cancer therapy monitoring. Computer-assisted analysis of baseline together with up to two follow-ups. / Apostolova, Ivalya; Renisch, S; Opfer, R; Derlin, Thorsten; Buchert, Ralph; Carlsen, I C; Brenner, Winfried.

in: NUKLEARMED-NUCL MED, Jahrgang 50, Nr. 2, 2, 2011, S. 83-92.

Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Zeitschriftenaufsatz › Forschung › Begutachtung

Harvard

Apostolova, I, Renisch, S, Opfer, R, Derlin, T, Buchert, R, Carlsen, IC & Brenner, W 2011, 'FDG PET/CT in cancer therapy monitoring. Computer-assisted analysis of baseline together with up to two follow-ups.', NUKLEARMED-NUCL MED, Jg. 50, Nr. 2, 2, S. 83-92. <http://www.ncbi.nlm.nih.gov/pubmed/21165536?dopt=Citation>

APA

Apostolova, I., Renisch, S., Opfer, R., Derlin, T., Buchert, R., Carlsen, I. C., & Brenner, W. (2011). FDG PET/CT in cancer therapy monitoring. Computer-assisted analysis of baseline together with up to two follow-ups. NUKLEARMED-NUCL MED, 50(2), 83-92. [2]. http://www.ncbi.nlm.nih.gov/pubmed/21165536?dopt=Citation

Vancouver

Apostolova I, Renisch S, Opfer R, Derlin T, Buchert R, Carlsen IC et al. FDG PET/CT in cancer therapy monitoring. Computer-assisted analysis of baseline together with up to two follow-ups. NUKLEARMED-NUCL MED. 2011;50(2):83-92. 2.

Bibtex

@article{031e6cc680cd4cf39c29fa79af5da1fa,
title = "FDG PET/CT in cancer therapy monitoring. Computer-assisted analysis of baseline together with up to two follow-ups.",
abstract = "Objectives: We developed and tested a software tool for computer-assisted analysis of FDG-PET/CT in cancer therapy monitoring. The tool provides automatic semi-quantitative analysis of a baseline scan together with up to two follow-up scans (standardized uptake values, glycolytic volume). The tool also supports visual analysis by local spatial registration which allows display of tumor lesions with the same orientation in all scans. The tool's stability and accuracy was tested at typical everyday image quality. Patients, methods: Ten unselected cancer patients in whom three FDG PET/CT scans had been performed were included. A total of 18 lesions were analyzed. Results: Automatic lesion tracking worked properly in all lesions but one. In this lesion local coregistration had to be adjusted manually which, however, is easily performed with the tool. Semi-automatic lesion segmentation and fully automatic semi-quantitative analysis worked properly in all cases. Computer-assisted analysis was significantly less time consuming than manual analysis. Conclusions: The novel software tool appears useful for analysis of FDG-PET/CT in cancer therapy monitoring in clinical routine patient care.",
author = "Ivalya Apostolova and S Renisch and R Opfer and Thorsten Derlin and Ralph Buchert and Carlsen, {I C} and Winfried Brenner",
year = "2011",
language = "Deutsch",
volume = "50",
pages = "83--92",
journal = "NUKLEARMED-NUCL MED",
issn = "0029-5566",
publisher = "Schattauer",
number = "2",

}

RIS

TY - JOUR

T1 - FDG PET/CT in cancer therapy monitoring. Computer-assisted analysis of baseline together with up to two follow-ups.

AU - Apostolova, Ivalya

AU - Renisch, S

AU - Opfer, R

AU - Derlin, Thorsten

AU - Buchert, Ralph

AU - Carlsen, I C

AU - Brenner, Winfried

PY - 2011

Y1 - 2011

N2 - Objectives: We developed and tested a software tool for computer-assisted analysis of FDG-PET/CT in cancer therapy monitoring. The tool provides automatic semi-quantitative analysis of a baseline scan together with up to two follow-up scans (standardized uptake values, glycolytic volume). The tool also supports visual analysis by local spatial registration which allows display of tumor lesions with the same orientation in all scans. The tool's stability and accuracy was tested at typical everyday image quality. Patients, methods: Ten unselected cancer patients in whom three FDG PET/CT scans had been performed were included. A total of 18 lesions were analyzed. Results: Automatic lesion tracking worked properly in all lesions but one. In this lesion local coregistration had to be adjusted manually which, however, is easily performed with the tool. Semi-automatic lesion segmentation and fully automatic semi-quantitative analysis worked properly in all cases. Computer-assisted analysis was significantly less time consuming than manual analysis. Conclusions: The novel software tool appears useful for analysis of FDG-PET/CT in cancer therapy monitoring in clinical routine patient care.

AB - Objectives: We developed and tested a software tool for computer-assisted analysis of FDG-PET/CT in cancer therapy monitoring. The tool provides automatic semi-quantitative analysis of a baseline scan together with up to two follow-up scans (standardized uptake values, glycolytic volume). The tool also supports visual analysis by local spatial registration which allows display of tumor lesions with the same orientation in all scans. The tool's stability and accuracy was tested at typical everyday image quality. Patients, methods: Ten unselected cancer patients in whom three FDG PET/CT scans had been performed were included. A total of 18 lesions were analyzed. Results: Automatic lesion tracking worked properly in all lesions but one. In this lesion local coregistration had to be adjusted manually which, however, is easily performed with the tool. Semi-automatic lesion segmentation and fully automatic semi-quantitative analysis worked properly in all cases. Computer-assisted analysis was significantly less time consuming than manual analysis. Conclusions: The novel software tool appears useful for analysis of FDG-PET/CT in cancer therapy monitoring in clinical routine patient care.

M3 - SCORING: Zeitschriftenaufsatz

VL - 50

SP - 83

EP - 92

JO - NUKLEARMED-NUCL MED

JF - NUKLEARMED-NUCL MED

SN - 0029-5566

IS - 2

M1 - 2

ER -